Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BYJHLT open

Waitlist mortality risk (US-CRS score) distribution among status 1 and 2 adult heart transplant candidates with exceptions.

4 affiliations
  1. 1Department of Surgery, NYU Grossman School of Medicine, New York, New York.
  2. 2Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  3. 3Department of Cardiothoracic Surgery, NYU Grossman School of Medicine, New York, New York.
  4. 4Department of Medicine, University of Chicago, Chicago, Illinois.

Abstract

The US-candidate risk score (US-CRS) predicts waitlist mortality among heart transplant candidates using 7 laboratory, cardiovascular, and cardiac device usage variables on a 50-point scale, with higher scores indicating greater mortality risk. We assessed whether US-CRS accurately assigns mortality risk for exception candidates, and whether the alignment of allocation priority with waitlist mortality risk (US-CRS) differs between candidates with and without exceptions. We compared the performance of US-CRS in candidates with and without exceptions using receiver operating curves. We compared US-CRS distributions using the Kolmogorov-Smirnov (KS) test and examined the proportion of candidates below specific score thresholds in each group. We also compared candidates with and without exceptions using Wilcoxon Rank-Sum test for continuous variables and Pearson's Chi-squared test or Fisher exact test for categorical variables. US-CRS is accurate for measuring mortality risk among exception candidates as it is among non-exception candidates. Patients with higher waitlist status had higher median US-CRS. However, the median US-CRS of Status 1 candidates without exceptions (50 [IQR 48-50]) was significantly higher than for candidates with exceptions (45 [36-48]; [ p≤0.05 ]), and similarly for Status 2 (46 [41-49] vs. 42 [32-47]; [ p≤0.05 ]). Notably, 33.13% of Status 1 and 41.28% of Status 2 candidates with exceptions had US-CRS below 40, compared to only 1.84% and 19.20% of candidates without exceptions, respectively. Conversely, among candidates in Status 3 and 4, candidates with exceptions generally had higher US-CRS than candidates without exceptions. Allocation priority under the status system does not align with estimated mortality risk; misalignment is greater for candidates with exceptions. While some exception candidates in Status 1 and 2 do have high estimated mortality risk and legitimately need exceptions, many of these exceptions appear to have been granted to candidates with relatively low medical urgency.

Related

  1. Insights Into the Revision of Heart Transplant Allocation Criteria ― Analysis of Waitlist Mortality and Transplant Probability for Adult Heart Transplant Candidates in the Nationwide Registry Data of Japan ―
    Juntaro Ashikari, Yasumasa Tsukamoto, Shinichi Nunoda +7
    Circulation JournalPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaJ-STAGE
  2. Waitlist mortality and post transplant survival amongst non-extracorporeal membrane oxygenation high-urgency heart transplant recipients before and after the 2018 policy change.
    John P White, Joseph Song, Samuel T Kim +9
    JTCVS openPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
  3. A Refined Lung Transplant Frailty Scale Incorporating Serum Albumin Is Associated With Risk of Mortality in Lung Transplant Candidates
    A. Sriram, J. Christie, M. R. Anderson +21
    medRxivPreprintCC BY-NC-NDFull textSurgery & anaesthesiamedRxiv
  4. Sex Differences in the Impact of Allosensitization on Waitlist Access and Post-Transplant Outcomes in Adults with Congenital Heart Disease
    A. Joseph, K. Kearney, C. Henricks +11
    medRxivPreprintAll rights reservedFull textSurgery & anaesthesiamedRxiv
  5. BioWaitIndex: a novel machine learning-derived biomarker for improved prediction of liver transplant waitlist outcomes.
    Khush Patel, Ashton A Connor, Mansi Sanghvi +19
    Frontiers in transplantationPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
BibTeX
@article{fatma2026waitlist,
  title = {{Waitlist mortality risk (US-CRS score) distribution among status 1 and 2 adult heart transplant candidates with exceptions.}},
  author = {Najiya Fatma and Suhani S Patel and Grace R Lyden and Nader Moazami and Brian Wayda and William F Parker and Sommer E Gentry},
  journal = {JHLT open},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jhlto.2026.100706},
  url = {https://europepmc.org/article/MED/42999889},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Waitlist mortality risk (US-CRS score) distribution among status 1 and 2 adult heart transplant candidates with exceptions.
AU  - Najiya Fatma
AU  - Suhani S Patel
AU  - Grace R Lyden
AU  - Nader Moazami
AU  - Brian Wayda
AU  - William F Parker
AU  - Sommer E Gentry
PY  - 2026
DA  - 2026/10/12
JO  - JHLT open
DO  - 10.1016/j.jhlto.2026.100706
UR  - https://europepmc.org/article/MED/42999889
AB  - The US-candidate risk score (US-CRS) predicts waitlist mortality among heart transplant candidates using 7 laboratory, cardiovascular, and cardiac device usage variables on a 50-point scale, with higher scores indicating greater mortality risk. We assessed whether US-CRS accurately assigns mortality risk for exception candidates, and whether the alignment of allocation priority with waitlist mortality risk (US-CRS) differs between candidates with and without exceptions. We compared the performance of US-CRS in candidates with and without exceptions using receiver operating curves. We compared US-CRS distributions using the Kolmogorov-Smirnov (KS) test and examined the proportion of candidates below specific score thresholds in each group. We also compared candidates with and without exceptions using Wilcoxon Rank-Sum test for continuous variables and Pearson's Chi-squared test or Fisher exact test for categorical variables. US-CRS is accurate for measuring mortality risk among exception candidates as it is among non-exception candidates. Patients with higher waitlist status had higher median US-CRS. However, the median US-CRS of Status 1 candidates without exceptions (50 [IQR 48-50]) was significantly higher than for candidates with exceptions (45 [36-48]; [ p≤0.05 ]), and similarly for Status 2 (46 [41-49] vs. 42 [32-47]; [ p≤0.05 ]). Notably, 33.13% of Status 1 and 41.28% of Status 2 candidates with exceptions had US-CRS below 40, compared to only 1.84% and 19.20% of candidates without exceptions, respectively. Conversely, among candidates in Status 3 and 4, candidates with exceptions generally had higher US-CRS than candidates without exceptions. Allocation priority under the status system does not align with estimated mortality risk; misalignment is greater for candidates with exceptions. While some exception candidates in Status 1 and 2 do have high estimated mortality risk and legitimately need exceptions, many of these exceptions appear to have been granted to candidates with relatively low medical urgency.
SN  - 2950-1334
ER  -